These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 978390)

  • 1. Pharmacodynamics of the antiarrhythmic disopyramide in healthy humans: correlation of the kinetics of the drug and its effects.
    Hinderling PH; Garrett ER
    J Pharmacokinet Biopharm; 1976 Jun; 4(3):231-42. PubMed ID: 978390
    [No Abstract]   [Full Text] [Related]  

  • 2. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the antiarrhythmic action of disopyramide by digoxin.
    García-Barreto D; Groning E; González-Gómez A; Pérez A; Hernández-Cañero A; Toruncha A
    J Cardiovasc Pharmacol; 1981; 3(6):1236-42. PubMed ID: 6173523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of the antiarrhythmic agent disopyramide phosphate (Norpace).
    Befeler B; Lazzara R
    Heart Lung; 1980; 9(3):475-82. PubMed ID: 6901520
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents.
    Ellrodt G; Singh BN
    Heart Lung; 1980; 9(3):469-74. PubMed ID: 6901519
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate.
    Mathur PP
    Am Heart J; 1972 Dec; 84(6):764-70. PubMed ID: 4150336
    [No Abstract]   [Full Text] [Related]  

  • 7. [Disopyramide: its mechanisms of action and clinical use].
    Härtel G
    Kardiologiia; 1985 Nov; 25(11):113-6. PubMed ID: 3910910
    [No Abstract]   [Full Text] [Related]  

  • 8. Disopyramide in patients with ventricular premature beats: an experimental model and preliminary results.
    Hohansson BW; Persson S
    J Int Med Res; 1976; 4(1 Suppl):96-9. PubMed ID: 1026538
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative comparison of the anticholinergic and antiarrhytmic actions of disopyramide and quinidine.
    Pérez A; Ledea N; Hermández K; Garcia-Barreto D
    Pol J Pharmacol Pharm; 1977; 29(5):527-32. PubMed ID: 593967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability.
    Bryson SM; Whiting B; Lawrence JR
    Br J Clin Pharmacol; 1978 Nov; 6(5):409-19. PubMed ID: 728284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of disopyramide on left ventricular performance: the relationship of free and total concentrations of the drug and of its mono-N-dealkylated metabolite to noninvasive indices of function.
    Holt GW; Norris RL; Ravenscroft PJ; Bett JH; Dryburgh LG; Boyle CM
    J Cardiovasc Pharmacol; 1983; 5(1):51-4. PubMed ID: 6186859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 13. Concurrent use of quinidine and disopyramide: evaluation of serum concentrations and electrocardiographic effects.
    Baker BJ; Gammill J; Massengill J; Schubert E; Karin A; Doherty JE
    Am Heart J; 1983 Jan; 105(1):12-5. PubMed ID: 6849225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of altered disopyramide binding on its pharmacologic response in rabbits.
    Huang JD; Oie S
    J Pharmacol Exp Ther; 1982 Nov; 223(2):469-71. PubMed ID: 7131300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of disopyramide phosphate in extrasystole at rest and on exercise (author's transl)].
    Stauch M; Grewe N; Nissen H
    MMW Munch Med Wochenschr; 1976 Mar; 118(11):331-4. PubMed ID: 57570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some aspects of the clinical pharmacology of intravenous disopyramide after myocardial infarction.
    Hillis WS; Tweddel A; Lorimer AR; Lawrie TD
    J Int Med Res; 1976; 4(1 Suppl):74-7. PubMed ID: 1026533
    [No Abstract]   [Full Text] [Related]  

  • 17. Disopyramide plasmakinetics and pharmacodynamics applied to the assessment of bioavailability [proceedings].
    Bryson SM; Lawrence JR; Whiting B
    Br J Clin Pharmacol; 1977 Oct; 4(5):633P. PubMed ID: 911618
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.
    Hinderling PH; Garrett ER
    J Pharmacokinet Biopharm; 1976 Jun; 4(3):199-230. PubMed ID: 978389
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiarrhythmic and electrocardiographic effects of single oral doses of disopyramide.
    Hulting J; Jansson B
    Eur J Clin Pharmacol; 1977 Jan; 11(2):91-9. PubMed ID: 320015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced metabolism and diminished efficacy of disopyramide by enzyme induction?
    Aitio ML; Vuorenmaa T
    Br J Clin Pharmacol; 1980 Feb; 9(2):149-52. PubMed ID: 7356902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.